Signaling Pathways - Flk-1 - adrenergic receptor - Myosin light chain kinases (MLCKs) - DOT1L
清除全部
-
B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂 -
B3523 Fasudil中文名: 法舒地尔Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 钙拮抗剂 -
B1358 Epinephrine Bitartrate中文名: 酒石酸肾上腺素Target: adrenergic receptorSummary: 肾上腺素能受体激动剂 -
B1572 LatrepirdineTarget: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptorSummary: 脑细胞死亡抑制剂 -
B1581 EPZ004777 HClTarget: DOT1LSummary: DOT1L抑制剂 -
B1438 BMS-794833Target: MET|Flk-1Summary: Met/VEGFR2抑制剂 -
A3744 Quetiapine中文名: 喹硫平Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptorSummary: 多巴胺受体拮抗剂 -
A3626 ML-7 hydrochlorideTarget: Myosin light chain kinases (MLCKs)Summary: 肌球蛋白轻链激酶抑制剂 -
A3374 Dronedarone中文名: 决奈达隆Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channelSummary: CYP3A4和2D6抑制剂 -
A4170 EPZ004777Target: DOT1LSummary: DOT1L抑制剂